LCI: [4-[[4-[5-(cyclopropylmethyl)-1-methyl-pyrazol-4-yl]-5-fluoranyl-pyrimidin-2-yl]amino]cyclohexyl]azanium
LCI is a Ligand Of Interest in 6GZD designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 6GZD_LCI_A_1018 | 57% | 7% | 0.117 | 0.89 | 2.11 | 2.56 | 6 | 13 | 2 | 0 | 100% | 1 |
| 6GZM_LCI_B_1003 | 93% | 10% | 0.058 | 0.96 | 1.94 | 2.23 | 5 | 12 | 0 | 0 | 100% | 1 |
| 6GZH_LCI_A_2001 | 83% | 7% | 0.095 | 0.96 | 2.23 | 2.45 | 6 | 11 | 1 | 0 | 100% | 1 |
